The older population consisting of persons aged 65 years or older is the fastest-growing
population group and also the major consumer of pharmaceutical products. Due to the …

Abstract Purpose of Review The global phenomenon of population aging is impacting the
health and care needs of society. The use of medications by older adults is acknowledged to …

Background Multimorbidity is increasing among older adults, but the impact of these recent
trends on the extent and complexity of polypharmacy and possible variation by sex remains …

Aims While certain drug‐use indicators are known to be associated with clinical outcomes,
the relationship is unclear for some highly prevalent conditions in in patients aged≥ 65 …

Background Estimates of polypharmacy have primarily been derived from prescription
claims, and less is known about the use of non-prescription medications (alone or in …

Abstract Background 1.5–8% of older adults live in nursing homes (NHs), presenting a high
prevalence of frailty and polypharmacy. Aims To investigate the association of frailty with …

Background Atrial fibrillation (AF) is relatively common among nursing home residents, and
decisions regarding anticoagulant therapy in this setting may be complicated by resident …

Background Chronic non-cancer pain is common among older residents of long-term care
(LTC) homes and often poorly recognized and treated. With heightened concerns regarding …

Background: Data on Canadian pharmacists' knowledge and perceptions about frailty in
older adults and its assessment in pharmacy practice are scarce. Methods: A cross-sectional …

Background Community pharmacists potentially have an important role to play in
identification of frailty and delivery of interventions to optimise medicines use for frail older …